Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
2.620
-0.220 (-7.75%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $14.24 million as of February 21, 2025. Its market cap has decreased by -48.12% in one year.
Market Cap
14.24M
Enterprise Value
-12.01M
1-Year Change
-48.12%
Ranking
Category
Stock Price
$2.62
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $14.24M, a decrease of -24.80%. That is a compound annual growth rate of -9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 14.24M | -20.36% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |